Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Lingji Zeng"'
Autor:
Chao Li, Maozhi Xiao, Suxia Geng, Yulian Wang, Lingji Zeng, Peilong Lai, Ying Gong, Xiaomei Chen
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionExploring monocytes’ roles within the tumor microenvironment is crucial for crafting targeted cancer treatments.MethodsThis study unveils a novel methodology utilizing four 20-color flow cytometry panels for comprehensive peripheral imm
Externí odkaz:
https://doaj.org/article/619d03afec874c2da889396cae455022
Autor:
Xiaomei Chen, Chao Li, Yulian Wang, Suxia Geng, Maozhi Xiao, Lingji Zeng, Chengxin Deng, Minming Li, Xin Huang, Jianyu Weng, Xin Du, Peilong Lai
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTThis study delves into the emerging role of ferroptosis in Myelodysplastic Neoplasms (MDS) and aims to identify a prognostic ferroptosis-related gene signature for MDS. Utilizing RNA-seq data and clinical information from the Gene Expression
Externí odkaz:
https://doaj.org/article/ce27c683265f4a74a24ebf72ffb89c5f
Autor:
Ruohao Xu, Miao Wu, Yawen Wang, Chao Li, Lingji Zeng, Yulian Wang, Maozhi Xiao, Xiaomei Chen, Suxia Geng, Peilong Lai, Xin Du, Jianyu Weng
Publikováno v:
Molecular Medicine, Vol 29, Iss 1, Pp 1-15 (2023)
Abstract Background Myofibroblasts (MFB), one of the major effectors of pathologic fibrosis, mainly derived from the activation of fibroblast to myofibroblast transition (FMT). Although MFBs were historically considered terminally differentiated cell
Externí odkaz:
https://doaj.org/article/8979a0f83a9b49db8b0e55c7d540f09f
Autor:
Jinghua Wang, Shuo Yang, Pengjun Liao, Lingji Zeng, Wei Ling, Li Wan, Jianyu Weng, Liye Zhong
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundThe t(11;14)(q13;32) is a common chromosome translocation in multiple myeloma (MM), but its prognostic value remains controversial. Immunoglobulin light chain amyloidosis is commonly secondary to multiple myeloma, which can rapidly cause he
Externí odkaz:
https://doaj.org/article/90f4c59178d545f9b02e823ef77fa195
Autor:
Xin Huang, Cunte Chen, Mengjun Zhong, Suxia Geng, Yujie Zhao, Minming Li, Chenxin Deng, Lingji Zeng, Ping Wu, Zesheng Lu, Jianyu Weng, Xin Du, Yangqiu Li
Publikováno v:
Biomarker Research, Vol 9, Iss 1, Pp 1-5 (2021)
Abstract Myelodysplastic syndrome (MDS) is an aggressive and genetically heterogeneous disease with poor prognosis. Cellular immune disorder is a common characteristic of this disease and is thought to be related to clinical outcome. Alterations in T
Externí odkaz:
https://doaj.org/article/fe401c4529e047ea846b89e606435bc8
Publikováno v:
Frontiers in Pediatrics, Vol 10 (2022)
ObjectiveTo investigate the correlation between gene mutations and glucocorticoid resistance in pediatric acute lymphoblastic leukemia (ALL).MethodsA total of 71 children with ALL admitted to our center between September 2019 and September 2021 were
Externí odkaz:
https://doaj.org/article/802ea3bc4b754cc995502bb7c57dd5e5
Autor:
Jianyu Weng, Peilong Lai, Le Qin, Yunxin Lai, Zhiwu Jiang, Chenwei Luo, Xin Huang, Suijing Wu, Dan Shao, Chengxin Deng, Lisi Huang, Zesheng Lu, Maohua Zhou, Lingji Zeng, Dongmei Chen, Yulian Wang, Xiaomei Chen, Suxia Geng, Weinkove Robert, Zhaoyang Tang, Chang He, Peng Li, Xin Du
Publikováno v:
Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-12 (2018)
Abstract Background Anti-CD19 chimeric antigen receptor (CAR) T cells have shown promise in the treatment of B cell acute lymphocytic leukemia (B-ALL). However, its efficacy in B-ALL patients with extramedullary involvement is limited due to poor res
Externí odkaz:
https://doaj.org/article/b6cf64a982b24109a2cbe0bb1860ee0d
Autor:
Jianyu Weng, Peilong Lai, Le Qin, Yunxin Lai, Zhiwu Jiang, Chenwei Luo, Xin Huang, Suijing Wu, Dan Shao, Chengxin Deng, Lisi Huang, Zesheng Lu, Maohua Zhou, Lingji Zeng, Dongmei Chen, Yulian Wang, Xiaomei Chen, Suxia Geng, Robert Weinkove, Zhaoyang Tang, Chang He, Peng Li, Xin Du
Publikováno v:
Journal of Hematology & Oncology, Vol 12, Iss 1, Pp 1-1 (2019)
The original article [1] contains an error in authorship whereby author, Robert Weinkove’s name is mistakenly inverted. The configuration noted in this Correction article should be considered instead along with author’s updated affiliation.
Externí odkaz:
https://doaj.org/article/9034878cc2c64cb99192bcb426542bd2
Autor:
Ruohao Xu, Suxia Geng, Lingji Zeng, Chengxin Deng, Xin Huang, Minming Li, Ping Wu, Peilong Lai, Jianyu Weng, Xin Du
Hypomethylating agents (HMAs) including azacitidine (AZA) represent the only FDA-approved first-line treatments for patients with chronic myelomonocytic leukemia (CMML). However, the mechanism by which HMAs produce therapeutic responses (e.g., hemato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c489c4b13e8ecd087772ebb686f4a9c7
https://doi.org/10.21203/rs.3.rs-2475679/v1
https://doi.org/10.21203/rs.3.rs-2475679/v1
Autor:
Xiaomei Chen, Yulian Wang, Xin Huang, Suxia Geng, Chao Li, Lingji Zeng, Lisi Huang, Xin Du, Jianyu Weng, Peilong Lai
Publikováno v:
International Immunopharmacology. 117:109746
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::558e9cff1534cd2cfd74681959ba9b61
https://doi.org/10.1016/j.intimp.2023.109746
https://doi.org/10.1016/j.intimp.2023.109746